Niche origin of mesenchymal stem cells derived microvesicles determines opposing effects on NSCLC: primary versus metastatic.
In conclusion, the systemic nature of MVs marks them as attractive therapeutic markers/targets and we propose that identification of specific cargoes/signals that differentiate between MSCs MVs of primary and metastatic niches may introduce fresh therapeutic approaches.
PMID: 31672605 [PubMed - as supplied by publisher]
Source: Cellular Signalling - Category: Cytology Authors: Attar-Schneider O, Dabbah M, Drucker L, Gottfried M Tags: Cell Signal Source Type: research
More News: Cancer | Cancer & Oncology | Cytology | Lung Cancer | Non-Small Cell Lung Cancer | Stem Cell Therapy | Stem Cells